Also from this source

You just read:

Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma

News provided by

Concordia Healthcare Corp.

Jan 13, 2014, 08:00 EST